Last updated on February 2019

Twelve -Month Study Observing How Insulin-na ve Patients With Type 2 Diabetes Mellitus Manage Diabetes Using Toujeo After Oral Antidiabetic Drug Failure the Side Effect of Toujeo and The Cost.


Brief description of study

Primary Objective:

Assess effectiveness of insulin glargine (U300) in achieving glycemic goal measured by hemoglobin A1c (HbA1c).

Secondary Objectives:

  • Assess effectiveness in achieving glycemic goal measured by HbA1c;
  • Assess effectiveness on change in HbA1c, fasting plasma glucose (FPG) and self-monitored plasma glucose (SMPG) ;
  • Assess requirement for intensification of therapy by additional antidiabetics.
  • Assess incidence of hypoglycemia;
  • Assess other safety endpoints: adverse events (AEs), serious adverse events (SAEs);
  • Assess change in body weight.

Detailed Study Description

Patients will be observed for one year

Clinical Study Identifier: NCT03703869

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.